-
Forward Look
Common-Sense ScreeningSigmoidoscopy may be a good option for colorectal cancer screening.
by Sue Rochman
-
Survivor Profile
Spreading the WordAn African-American banking pioneer finds fulfillment in increasing prostate cancer awareness.
by Yvonne Lee
-
Forward Look
Fertility Preservation Catches On, But SlowlyNew cancer patients need information and quick referrals to infertility specialists.
by Charlotte Huff
-
Q&A
Facing the CriticsRoger Ebert finds peace with his appearance following disfiguring cancer surgery.
by Ronni Gordon
-
The Survival Gap
In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Forward Look
The Dense Breast DebateSome states are mandating that doctors tell patients about breast density, which can affect cancer risk.
by Mitzi Baker
-
Get Involved
One Young Survivor Helping AnotherA teen who survived cancer is raising money to help others.
by Yvonne Lee
-
Yesterday & Today
A Touch of MagicElizabeth Montgomery led a bewitching life that was cut short by colorectal cancer in 1995.
by Sue Rochman
-
Forward Look
When Is “Cancer” Not Cancer?Does the word “cancer” discourage patients with very early disease from fully considering all their options?
by Stephen Ornes
Cancer Talk
Understanding How High and Low Testosterone Levels Can Treat Prostate Cancer
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose